Prognostic Role of Peripheral Neutrophil-Lymphocyte Ratio (NLR) and Platelet-Lymphocyte Ratio (PLR) in Patients with Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy

[1] Sauer R(2004)German rectal cancer study group. Preoperative versus postoperative chemoradiotherapy for rectal cancer N Engl J Med 351 1731-1740

[2] Becker H(2012)Systematic review, and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer Br J Surg 99 918-928

[3] Hohenberger W(2009)Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03 J Clin Oncol 27 5124-5130

[4] Rödel C(2012)Neoadjuvant treatment response as an early response indicator for patients with rectal cancer J Clin Oncol 30 1770-1776

[5] Wittekind C(2018)Oncological and survival outcomes in watch and wait patients with a clinical complete response after neoadjuvant chemoradiotherapy for rectal cancer: a systematic review and pooled analysis Ann Surg 268 955-967

[6] Fietkau R(2012)The relationship between tumor inflammatory cell infiltrate and outcome in patients with pancreatic ductal adenocarcinoma Ann Surg Oncol 19 3581-3590

[7] Martus P(2013)C-reactive protein as predictor of recurrence in patients with rectal cancer undergoing chemoradiotherapy followed by surgery Anticancer Res 33 5065-5074

[8] Tschmelitsch J(2015)The neutrophil-platelet score (NPS) predicts survival in primary operable colorectal cancer and a variety of common cancers PLoS One 10 e0142159-e707

[9] Hager E(2012)Systemic inflammatory response is a predictor of outcome in patients undergoing preoperative chemoradiation for locally advanced rectal cancer Color Dis 14 e701-2456

[10] Hess CF(2019)Neutrophil-to-lymhocyte ratio in rectal cancer—novel biomarker of tumor immunogenicity during radiotherapy or confounding variable? Int J Mol Sci 20 2448-199

[1] Sauer R(2004)German rectal cancer study group. Preoperative versus postoperative chemoradiotherapy for rectal cancer N Engl J Med 351 1731-1740

[2] Becker H(2012)Systematic review, and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer Br J Surg 99 918-928

[3] Hohenberger W(2009)Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03 J Clin Oncol 27 5124-5130

[4] Rödel C(2012)Neoadjuvant treatment response as an early response indicator for patients with rectal cancer J Clin Oncol 30 1770-1776

[5] Wittekind C(2018)Oncological and survival outcomes in watch and wait patients with a clinical complete response after neoadjuvant chemoradiotherapy for rectal cancer: a systematic review and pooled analysis Ann Surg 268 955-967

[6] Fietkau R(2012)The relationship between tumor inflammatory cell infiltrate and outcome in patients with pancreatic ductal adenocarcinoma Ann Surg Oncol 19 3581-3590

[7] Martus P(2013)C-reactive protein as predictor of recurrence in patients with rectal cancer undergoing chemoradiotherapy followed by surgery Anticancer Res 33 5065-5074

[8] Tschmelitsch J(2015)The neutrophil-platelet score (NPS) predicts survival in primary operable colorectal cancer and a variety of common cancers PLoS One 10 e0142159-e707

[9] Hager E(2012)Systemic inflammatory response is a predictor of outcome in patients undergoing preoperative chemoradiation for locally advanced rectal cancer Color Dis 14 e701-2456

[10] Hess CF(2019)Neutrophil-to-lymhocyte ratio in rectal cancer—novel biomarker of tumor immunogenicity during radiotherapy or confounding variable? Int J Mol Sci 20 2448-199